Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sagopilone and carboplatin in recurrent ovarian cancer
NCT00325351Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2006
- Primary completion
- Jul 2008
- Countries
- 2
01
Overview
A Phase 2 trial of sagopilone in ovarian cancer, sponsored by Bayer. Started Aug 2006; status: completed.
02
Drugs
sagopilone
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00325351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325351.